From Bay Area Biotech Startup at Odds with Dana-Farber and Novartis Over Cancer Drug Rights:

Dana-Farber complaint

Dana-Farber complaint—

Dana-Farber Cancer Institute’s complaint against Gatekeeper Pharmaceuticals, filed 9/21/10. Click icon above to download the pdf.

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
How to Approach Life Sciences Fundraising
Explore the different sources of funding, their relative merits, and how you should best utilize that funding at each stage of your research
Brex

From Our Partners · Special Report
Robert Langer reveals secrets to early-stage biotech success
Advice for funding and future transformational opportunities

From Our Editors · Special Report
Xcelerating Life Sciences Philadelphia: Special Report
Becoming the Cell & Gene Therapy Hub

Xconomy on Demand

We offer a number of ways to subscribe for free!